Were you the victim of Arkadios Capital broker Stephen Ferencik (CRD# 3126037)? Ferencik has been registered with Arkadios Capital in Atlanta, Georgia since 2017. After that time, Ferencik was registered with Triad Advisors, Inc. in Atlanta, Georgia from 2011 to 2017 and with ACG Wealth Inc. in Atlanta, Georgia from 2010 to 2021.
Previously, Ferenick was registered with UBS Financial Services Inc. in Atlanta, Georgia from 2005 to 2010, when he was terminated regarding, “Mr. Ferencik exercised time discretion, in violation of firm policy, despite being previously reprimanded by the firm for similar conduct.”
Ferencik has been the subject of nine customer complaints between 2004 and 2021, two of which were denied, according to his CRD report. The most recent complaints are regarding:
- April 2021. “Unsuitable Products Worked with rep 2017-2021.” The customer is seeking $200,000 in damages and the case is currently pending. The complaint was regarding alternative investments and took place while Ferencik was registered with Arkadios Capital.
- May 2020. “Unsuitable product during 2018-2019.” The case is currently pending. The complaint was regarding structured notes and took place while Ferencik was registered with ACG Wealth.
- April 2020. “Unsuitable product during 2018-2019.” The case is currently pending. The complaint was regarding structured notes and took place while Ferencik was registered with ACG Wealth.
Pursuant to FINRA Rules, member firms are responsible for supervising a broker’s activities during the time the broker is registered with the firm. Therefore, Arkadios Capital may be liable for investment or other losses suffered by Ferencik’s customers.
Erez Law represents investors in the United States for claims against brokers and brokerage firms for wrongdoing. If you have experienced investment losses, please call us at 888-840-1571 or complete our contact form for a free consultation. Erez Law is a nationally recognized law firm representing individuals, trusts, corporations and institutions in claims against brokerage firms, banks and insurance companies on a contingency fee basis.
"*" indicates required fields